A little more reflection and I’ve discovered a trend (could be called a flaw) in how I evaluate stocks and perhaps I overvalue unique technologies…a few examples…
I was an early investor in GTAT who really liked the concept of growing crystals (sapphire in particular). I managed to exit with a 150% gain not because I’m so smart but because the stock looked erratic and I was going to be out of touch for 4 weeks and if things settled down, I could rebuy…it tanked instead. A big winner but not of my doing.
I bought a tiny piece of Movano Health (MOVE) not because of the LQMT connection but because of their unique RF measurement technology…..80% loss on a $1k plunge…but again
I bought Burcon NutriScience for their unique extraction process for getting ultra pure protein from canola. .Great product with no market “pull” …sound familiar?
Obviously, there were many that worked out but these are the ones associated with new, unique technologies pushing for commercialization and acceptance. It’s easy to underestimate the risks associated with bringing a new technology to market. It takes longer, costs more, new competitors may appear and there may not be a market when all is said and done.
Happy New Year
Market Data 
Markets 
AI
